中华骨质疏松和骨矿盐疾病杂志
中華骨質疏鬆和骨礦鹽疾病雜誌
중화골질소송화골광염질병잡지
CHINESE JOURNAL OF OSTEOPOROSIS AND BONE MINERAL RESEARCH
2014年
4期
320-324
,共5页
宁志伟%苗莉%刘佳%胡延晋%高霞%潘永华%孙红%徐援%刘丽宏
寧誌偉%苗莉%劉佳%鬍延晉%高霞%潘永華%孫紅%徐援%劉麗宏
저지위%묘리%류가%호연진%고하%반영화%손홍%서원%류려굉
维生素D缺乏症%维生素D3%治疗%25-羟基维生素D%甲状旁腺激素
維生素D缺乏癥%維生素D3%治療%25-羥基維生素D%甲狀徬腺激素
유생소D결핍증%유생소D3%치료%25-간기유생소D%갑상방선격소
vitamin D deficiency%vitamin D3%treatment%25-hydroxyvitamin D%parathyroid hormone
目的:寻找治疗维生素D缺乏有效且依从性良好的治疗方案,为寻找治疗维生素D缺乏症的理想治疗方案提供依据。方法采用前瞻性干预方法,给予62例维生素D缺乏症患者单次口服60万单位负荷剂量维生素D3,观察用药第4、30、60和90天血钙、磷、尿钙和血清25OHD和甲状旁腺素( PTH)水平。结果患者血清25OHD水平基线值为(8.9±2.9) ng/mL,用药第4天为(58.9±11.1) ng/mL,第90天为(30.3±9.6) ng/mL,差异均有统计学意义(均P<0.001); PTH基线值水平为(66.6±30.2) pg/mL,用药第4天降至(32.7±21.6) pg/mL,第90天为(38.8±18.3) pg/mL,差异均有统计学意义(均P<0.001);用药后不同时点血钙与和血磷均较基线水平升高,但在正常值范围内;尿钙水平在用药第4天显著升高,但高尿钙患者未见明显增多。所有受试者均未出现泌尿系结石。结论单次口服60万单位负荷剂量维生素D3,可快速纠正维生素D缺乏,维持血清25OHD理想水平并持续3个月,该治疗方案可有效逆转继发性甲状旁腺功能亢进,且未增加发生高钙血症和高尿钙的危险。
目的:尋找治療維生素D缺乏有效且依從性良好的治療方案,為尋找治療維生素D缺乏癥的理想治療方案提供依據。方法採用前瞻性榦預方法,給予62例維生素D缺乏癥患者單次口服60萬單位負荷劑量維生素D3,觀察用藥第4、30、60和90天血鈣、燐、尿鈣和血清25OHD和甲狀徬腺素( PTH)水平。結果患者血清25OHD水平基線值為(8.9±2.9) ng/mL,用藥第4天為(58.9±11.1) ng/mL,第90天為(30.3±9.6) ng/mL,差異均有統計學意義(均P<0.001); PTH基線值水平為(66.6±30.2) pg/mL,用藥第4天降至(32.7±21.6) pg/mL,第90天為(38.8±18.3) pg/mL,差異均有統計學意義(均P<0.001);用藥後不同時點血鈣與和血燐均較基線水平升高,但在正常值範圍內;尿鈣水平在用藥第4天顯著升高,但高尿鈣患者未見明顯增多。所有受試者均未齣現泌尿繫結石。結論單次口服60萬單位負荷劑量維生素D3,可快速糾正維生素D缺乏,維持血清25OHD理想水平併持續3箇月,該治療方案可有效逆轉繼髮性甲狀徬腺功能亢進,且未增加髮生高鈣血癥和高尿鈣的危險。
목적:심조치료유생소D결핍유효차의종성량호적치료방안,위심조치료유생소D결핍증적이상치료방안제공의거。방법채용전첨성간예방법,급여62례유생소D결핍증환자단차구복60만단위부하제량유생소D3,관찰용약제4、30、60화90천혈개、린、뇨개화혈청25OHD화갑상방선소( PTH)수평。결과환자혈청25OHD수평기선치위(8.9±2.9) ng/mL,용약제4천위(58.9±11.1) ng/mL,제90천위(30.3±9.6) ng/mL,차이균유통계학의의(균P<0.001); PTH기선치수평위(66.6±30.2) pg/mL,용약제4천강지(32.7±21.6) pg/mL,제90천위(38.8±18.3) pg/mL,차이균유통계학의의(균P<0.001);용약후불동시점혈개여화혈린균교기선수평승고,단재정상치범위내;뇨개수평재용약제4천현저승고,단고뇨개환자미견명현증다。소유수시자균미출현비뇨계결석。결론단차구복60만단위부하제량유생소D3,가쾌속규정유생소D결핍,유지혈청25OHD이상수평병지속3개월,해치료방안가유효역전계발성갑상방선공능항진,차미증가발생고개혈증화고뇨개적위험。
Objective We evaluated the effect of a single high dose of vitamin D3 on serum level of 25-hydroxyvitamin, parathyroid hormone, and serum calcium and phosphorus level and urine calcium excretion at 4, 30, 60 and 90 d, compared to baseline .Methods Sixty-two subjects with vitamin D deficiency participated in this pro-spective intervention study.A single bolus oral dose of 600, 000 IU of vitamin D3 was administered to each subject. Serum changes of 25-hydroxyvitamin D (25OHD), PTH, calcium, and phosphorus level and urine calcium excretion induced by a single load of vitamin D3 were evaluated.Results The 25OHD level was (8.9 ±2.9) ng/mL at baseline and became (58.9 ±11.1) ng/mL at 4 d (P<0.001) and (30.3 ±9.6) ng/mL at 90 d (P<0.001).PTH lev-els concomitantly decreased from (66.6 ±30.2) pg/mL to (32.7 ±21.6) pg/mL at 4 d and to (38.8 ±18.3) pg/mL at 90 d (P<0.001 for both).Mean serum Ca and P significantly increased compared to baseline , but all were still in nor-mal range.No increased hypercalcemia patients were found .Conclusion A single bolus oral dose of 600 000 U of vita-min D3 rapidly corrects vitamin D deficiency and serum 25 ( OH) D keeps ideal level lasting for 3 months.Secondary hy-perparathyroidism concomitant with vitamin D deficiency were effectively reversed .No increased risk of hypercalcemia and hypercalciuria were found for the treatment .It's a promising treatment regimen in the management of vitamin D deficiency .